MyFinsight
Home
Blog
About
Back
Income Statement
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC)
source: myfinsight.com
Net loss
attributable to common...
-$2,570,709
(-48.31%↓ Y/Y)
Net gain
attributable to...
-$166
(0.00%↑ Y/Y)
Other income and
expense, net
$5,834
(-72.23%↓ Y/Y)
Net loss
-$2,570,875
(-48.30%↓ Y/Y)
Total other income
(expense), net
$5,514
(-67.56%↓ Y/Y)
Interest expense, net
$320
(-89.87%↓ Y/Y)
Loss from operations
-$2,576,389
(-47.18%↓ Y/Y)
Federal grants
$1,164,315
(-15.10%↓ Y/Y)
Total operating
expenses
$3,740,704
(19.82%↑ Y/Y)
Research and development
$2,471,752
(28.51%↑ Y/Y)
General and
administrative
$1,268,952
(5.88%↑ Y/Y)
Back